-
1
-
-
0037005813
-
Confirmation of a heart failure epidemic: Findings from the Resource Utilization among Congestive Heart Failure (REACH) study
-
McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002;39:60-69
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 60-69
-
-
McCullough, P.A.1
Philbin, E.F.2
Spertus, J.A.3
Kaatz, S.4
Sandberg, K.R.5
Weaver, W.D.6
-
2
-
-
43549099569
-
Biomarkers in heart failure
-
Braunwald E. Biomarkers in heart failure. N Engl J Med 2008;358:2148-2159
-
(2008)
N Engl J Med
, vol.358
, pp. 2148-2159
-
-
Braunwald, E.1
-
3
-
-
1442265589
-
Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea
-
DOI 10.1056/NEJMoa031681
-
Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647-654 (Pubitemid 38364623)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.7
, pp. 647-654
-
-
Mueller, C.1
Scholer, A.2
Laule-Kilian, K.3
Martina, B.4
Schindler, C.5
Buser, P.6
Pfisterer, M.7
Perruchoud, A.P.8
-
4
-
-
1242295182
-
Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure
-
DOI 10.1016/j.jacc.2003.09.044
-
Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004;43:635-641 (Pubitemid 38229537)
-
(2004)
Journal of the American College of Cardiology
, vol.43
, Issue.4
, pp. 635-641
-
-
Logeart, D.1
Thabut, G.2
Jourdain, P.3
Chavelas, C.4
Beyne, P.5
Beauvais, F.6
Bouvier, E.7
Solal, A.C.8
-
5
-
-
1642463859
-
Inflammatory mediators in chronic heart failure: An overview
-
Anker SD, von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart 2004;90:464-470 (Pubitemid 38406929)
-
(2004)
Heart
, vol.90
, Issue.4
, pp. 464-470
-
-
Anker, S.D.1
Von Haehling, S.2
-
7
-
-
64949139676
-
Oxidative stress induces myeloperoxidase expression in endocardial endothelial cells from patients with chronic heart failure
-
La Rocca G, Di Stefano A, Eleuteri E, Anzalone R, Magno F, Corrao S, et al. Oxidative stress induces myeloperoxidase expression in endocardial endothelial cells from patients with chronic heart failure. Basic Res Cardiol 2009;104:307-320
-
(2009)
Basic Res Cardiol
, vol.104
, pp. 307-320
-
-
La Rocca, G.1
Di Stefano, A.2
Eleuteri, E.3
Anzalone, R.4
Magno, F.5
Corrao, S.6
-
8
-
-
0042626223
-
Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment
-
Brennan ML, Hazen SL. Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment. Curr Opin Lipidol 2003; 14:353-359
-
(2003)
Curr Opin Lipidol
, vol.14
, pp. 353-359
-
-
Brennan, M.L.1
Hazen, S.L.2
-
9
-
-
0037189377
-
Myeloperoxidase, a leukocyte-derived vascular NO oxidase
-
Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science (Wash DC) 2002;296:2391-2394
-
(2002)
Science (Wash DC)
, vol.296
, pp. 2391-2394
-
-
Eiserich, J.P.1
Baldus, S.2
Brennan, M.L.3
Ma, W.4
Zhang, C.5
Tousson, A.6
-
10
-
-
0030979720
-
3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima
-
Hazen SL, Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 1997;99:2075-2081
-
(1997)
J Clin Invest
, vol.99
, pp. 2075-2081
-
-
Hazen, S.L.1
Heinecke, J.W.2
-
11
-
-
0142089171
-
Prognostic value of myeloperoxidase in patients with chest pain
-
Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003;349:1595-1604
-
(2003)
N Engl J Med
, vol.349
, pp. 1595-1604
-
-
Brennan, M.L.1
Penn, M.S.2
Van Lente, F.3
Nambi, V.4
Shishehbor, M.H.5
Aviles, R.J.6
-
12
-
-
0141727730
-
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes
-
Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003;108:1440-1445
-
(2003)
Circulation
, vol.108
, pp. 1440-1445
-
-
Baldus, S.1
Heeschen, C.2
Meinertz, T.3
Zeiher, A.M.4
Eiserich, J.P.5
Munzel, T.6
-
13
-
-
33748060845
-
Plasma myeloperoxidase levels in patients with chronic heart failure
-
Tang WH, Brennan ML, Philip K, Tong W, Mann S, Van Lente F, Hazen SL. Plasma myeloperoxidase levels in patients with chronic heart failure. Am J Cardiol 2006;98:796-799
-
(2006)
Am J Cardiol
, vol.98
, pp. 796-799
-
-
Tang, W.H.1
Brennan, M.L.2
Philip, K.3
Tong, W.4
Mann, S.5
Van Lente, F.6
Hazen, S.L.7
-
14
-
-
59449098393
-
Usefulness of serum myeloperoxidase in prediction of mortality in patients with severe heart failure
-
Michowitz Y, Kisil S, Guzner-Gur H, Rubinstein A, Wexler D, Sheps D, et al. Usefulness of serum myeloperoxidase in prediction of mortality in patients with severe heart failure. Isr Med Assoc J 2008;10:884-888
-
(2008)
Isr Med Assoc J
, vol.10
, pp. 884-888
-
-
Michowitz, Y.1
Kisil, S.2
Guzner-Gur, H.3
Rubinstein, A.4
Wexler, D.5
Sheps, D.6
-
15
-
-
34249983168
-
Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure
-
Tang WH, Tong W, Troughton RW, Martin MG, Shrestha K, Borowski A, et al. Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure. J Am Coll Cardiol 2007;49:2364-2370
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 2364-2370
-
-
Tang, W.H.1
Tong, W.2
Troughton, R.W.3
Martin, M.G.4
Shrestha, K.5
Borowski, A.6
-
16
-
-
53249090182
-
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology
-
Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
-
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-2442
-
(2008)
Eur Heart J
, vol.29
, pp. 2388-2442
-
-
Dickstein, K.1
Cohen-Solal, A.2
Filippatos, G.3
McMurray, J.J.4
Ponikowski, P.5
Poole-Wilson, P.A.6
-
17
-
-
77952961218
-
Evaluation of the ARCHITECT MPO Assay
-
Hoffman J, Lloyd C, Newhart A, Parsons R, Ford K. Evaluation of the ARCHITECT MPO Assay. Clin Chem 2008;54(S6):A85-6.
-
(2008)
Clin Chem
, vol.54
, Issue.S6
-
-
Hoffman, J.1
Lloyd, C.2
Newhart, A.3
Parsons, R.4
Ford, K.5
-
18
-
-
33747120659
-
Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate
-
Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145: 247-254
-
(2006)
Ann Intern Med
, vol.145
, pp. 247-254
-
-
Levey, A.S.1
Coresh, J.2
Greene, T.3
Stevens, L.A.4
Zhang, Y.L.5
Hendriksen, S.6
-
19
-
-
0023710206
-
Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach
-
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44: 837-845
-
(1988)
Biometrics
, vol.44
, pp. 837-845
-
-
DeLong, E.R.1
DeLong, D.M.2
Clarke-Pearson, D.L.3
-
20
-
-
12844281204
-
Risk stratification for inhospital mortality in acutely decompensated heart failure: Classification and regression tree analysis
-
Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ. Risk stratification for inhospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005;293:572-580
-
(2005)
JAMA
, vol.293
, pp. 572-580
-
-
Fonarow, G.C.1
Adams Jr., K.F.2
Abraham, W.T.3
Yancy, C.W.4
Boscardin, W.J.5
-
21
-
-
71149093112
-
Diagnostic and prognostic value of uric acid in patients with acute dyspnea
-
e7-14
-
Reichlin T, Potocki M, Breidthardt T, Noveanu M, Hartwiger S, Burri E, et al. Diagnostic and prognostic value of uric acid in patients with acute dyspnea. Am J Med 2009;122:1054 e7-14.
-
(2009)
Am J Med
, vol.122
, pp. 1054
-
-
Reichlin, T.1
Potocki, M.2
Breidthardt, T.3
Noveanu, M.4
Hartwiger, S.5
Burri, E.6
-
22
-
-
0034534961
-
Nitric oxide is a physiological substrate for mammalian peroxidases
-
Abu-Soud HM, Hazen SL. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem 2000;275:37524-37532
-
(2000)
J Biol Chem
, vol.275
, pp. 37524-37532
-
-
Abu-Soud, H.M.1
Hazen, S.L.2
-
23
-
-
77949492291
-
Liberation of vessel adherent myeloperoxidase by enoxaparin improves endothelial function
-
Rudolph TK, Rudolph V, Witte A, Klinke A, Szoecs K, Lau D, et al. Liberation of vessel adherent myeloperoxidase by enoxaparin improves endothelial function. Int J Cardiol 2010;140:42-47
-
(2010)
Int J Cardiol
, vol.140
, pp. 42-47
-
-
Rudolph, T.K.1
Rudolph, V.2
Witte, A.3
Klinke, A.4
Szoecs, K.5
Lau, D.6
-
24
-
-
0037416219
-
Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction
-
Askari AT, Brennan ML, Zhou X, Drinko J, Morehead A, Thomas JD, et al. Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med 2003;197:615-624
-
(2003)
J Exp Med
, vol.197
, pp. 615-624
-
-
Askari, A.T.1
Brennan, M.L.2
Zhou, X.3
Drinko, J.4
Morehead, A.5
Thomas, J.D.6
-
25
-
-
27844442307
-
Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction
-
Vasilyev N, Williams T, Brennan ML, Unzek S, Zhou X, Heinecke JW, et al. Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction. Circulation 2005;112:2812-2820
-
(2005)
Circulation
, vol.112
, pp. 2812-2820
-
-
Vasilyev, N.1
Williams, T.2
Brennan, M.L.3
Unzek, S.4
Zhou, X.5
Heinecke, J.W.6
-
26
-
-
34548481068
-
Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function
-
Rudolph V, Rudolph TK, Hennings JC, Blankenberg S, Schnabel R, Steven D, et al. Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function. Free Radic Biol Med 2007;43:1189-1196
-
(2007)
Free Radic Biol Med
, vol.43
, pp. 1189-1196
-
-
Rudolph, V.1
Rudolph, T.K.2
Hennings, J.C.3
Blankenberg, S.4
Schnabel, R.5
Steven, D.6
-
27
-
-
67349251547
-
Increased nitrotyrosine plasma levels in relation to systemic markers of inflammation and myeloperoxidase in chronic heart failure
-
Eleuteri E, Di Stefano A, Ricciardolo FL, Magno F, Gnemmi I, Colombo M, et al. Increased nitrotyrosine plasma levels in relation to systemic markers of inflammation and myeloperoxidase in chronic heart failure. Int J Cardiol 2009;135:386-390
-
(2009)
Int J Cardiol
, vol.135
, pp. 386-390
-
-
Eleuteri, E.1
Di Stefano, A.2
Ricciardolo, F.L.3
Magno, F.4
Gnemmi, I.5
Colombo, M.6
-
28
-
-
65249159202
-
Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure
-
Tang WH, Katz R, Brennan ML, Aviles RJ, Tracy RP, Psaty BM, Hazen SL. Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure. Am J Cardiol 2009;103:1269-1274
-
(2009)
Am J Cardiol
, vol.103
, pp. 1269-1274
-
-
Tang, W.H.1
Katz, R.2
Brennan, M.L.3
Aviles, R.J.4
Tracy, R.P.5
Psaty, B.M.6
Hazen, S.L.7
-
29
-
-
33745673598
-
Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure
-
Ng LL, Pathik B, Loke IW, Squire IB, Davies JE. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure. Am Heart J 2006;152:94-101.
-
(2006)
Am Heart J
, vol.152
, pp. 94-101
-
-
Ng, L.L.1
Pathik, B.2
Loke, I.W.3
Squire, I.B.4
Davies, J.E.5
-
30
-
-
58149263078
-
Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea
-
Shah KB, Kop WJ, Christenson RH, Diercks DB, Kuo D, Henderson S, et al. Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea. Clin Chem 2009;55:59-67.
-
(2009)
Clin Chem
, vol.55
, pp. 59-67
-
-
Shah, K.B.1
Kop, W.J.2
Christenson, R.H.3
Diercks, D.B.4
Kuo, D.5
Henderson, S.6
-
31
-
-
33947714353
-
Myeloperoxidase as a marker of increasing systemic inflammation in smokers without severe airway symptoms
-
Andelid K, Bake B, Rak S, Linden A, Rosengren A, Ekberg-Jansson A. Myeloperoxidase as a marker of increasing systemic inflammation in smokers without severe airway symptoms. Respir Med 2007;101:888-895
-
(2007)
Respir Med
, vol.101
, pp. 888-895
-
-
Andelid, K.1
Bake, B.2
Rak, S.3
Linden, A.4
Rosengren, A.5
Ekberg-Jansson, A.6
-
32
-
-
0035030757
-
Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: The effect of immunotherapy
-
Monteseirin J, Bonilla I, Camacho J, Conde J, Sobrino F. Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: the effect of immunotherapy. J Allergy Clin Immunol 2001; 107:623-626
-
(2001)
J Allergy Clin Immunol
, vol.107
, pp. 623-626
-
-
Monteseirin, J.1
Bonilla, I.2
Camacho, J.3
Conde, J.4
Sobrino, F.5
-
33
-
-
33847287411
-
Relationship between airway colonization, inflammation and exacerbation frequency in COPD
-
Tumkaya M, Atis S, Ozge C, Delialioglu N, Polat G, Kanik A. Relationship between airway colonization, inflammation and exacerbation frequency in COPD. Respir Med 2007;101:729-737
-
(2007)
Respir Med
, vol.101
, pp. 729-737
-
-
Tumkaya, M.1
Atis, S.2
Ozge, C.3
Delialioglu, N.4
Polat, G.5
Kanik, A.6
-
34
-
-
77952430959
-
Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: A randomized placebo-controlled study
-
Andreou I, Tousoulis D, Miliou A, Tentolouris C, Zisimos K, Gounari P, et al. Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study. Atherosclerosis 2010;210: 194-198
-
(2010)
Atherosclerosis
, vol.210
, pp. 194-198
-
-
Andreou, I.1
Tousoulis, D.2
Miliou, A.3
Tentolouris, C.4
Zisimos, K.5
Gounari, P.6
-
35
-
-
14844291419
-
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
-
Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209-216
-
(2005)
Am Heart J
, vol.149
, pp. 209-216
-
-
Adams Jr., K.F.1
Fonarow, G.C.2
Emerman, C.L.3
Lejemtel, T.H.4
Costanzo, M.R.5
Abraham, W.T.6
-
36
-
-
0037336371
-
The EuroHeart Failure survey programme: A survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis
-
Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. The EuroHeart Failure survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-463
-
(2003)
Eur Heart J
, vol.24
, pp. 442-463
-
-
Cleland, J.G.1
Swedberg, K.2
Follath, F.3
Komajda, M.4
Cohen-Solal, A.5
Aguilar, J.C.6
-
37
-
-
58149218178
-
Novel biomarkers of cardiovascular disease: Myeloperoxidase for acute and/or chronic heart failure?
-
Wu AH. Novel biomarkers of cardiovascular disease: myeloperoxidase for acute and/or chronic heart failure? Clin Chem 2009;55:12-14
-
(2009)
Clin Chem
, vol.55
, pp. 12-14
-
-
Wu, A.H.1
-
38
-
-
0037130155
-
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
-
Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161-167
-
(2002)
N Engl J Med
, vol.347
, pp. 161-167
-
-
Maisel, A.S.1
Krishnaswamy, P.2
Nowak, R.M.3
McCord, J.4
Hollander, J.E.5
Duc, P.6
-
39
-
-
20144388239
-
The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study
-
Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005;95:948-954
-
(2005)
Am J Cardiol
, vol.95
, pp. 948-954
-
-
Januzzi Jr., J.L.1
Camargo, C.A.2
Anwaruddin, S.3
Baggish, A.L.4
Chen, A.A.5
Krauser, D.G.6
-
40
-
-
0030023077
-
Exploration of the precision of classifying sudden cardiac death: Implications for the interpretation of clinical trials
-
Pratt CM, Greenway PS, Schoenfeld MH, Hibben ML, Reiffel JA. Exploration of the precision of classifying sudden cardiac death: implications for the interpretation of clinical trials. Circulation 1996;93:519-524
-
(1996)
Circulation
, vol.93
, pp. 519-524
-
-
Pratt, C.M.1
Greenway, P.S.2
Schoenfeld, M.H.3
Hibben, M.L.4
Reiffel, J.A.5
|